Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 35
Filtrar
1.
Eur J Surg Oncol ; 48(1): 292-298, 2022 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-34503849

RESUMO

BACKGROUND: Spinal metastases (SpMs) from thyroid cancers (TC) significantly reduce quality of life by causing pain, neurological deficits in addition to increasing mortality. Moreover, prognosis factors including surgery remain debated. METHODS: Data were stored in a prospective French national multicenter database of patients treated for SpM between January 2014 and 2017. Fifty-one consecutive patients affected by TC with 173 secondary SpM were included. RESULTS: Mean overall survival (OS) time for all patients from the diagnosis of a thyroid SpM event was 9.1 years (SD 8.7 months). The 1-year, 5-year and 10-year survival estimates were 94% (SD 3.3), 83.8.0% (SD 5.2), and 74.5% (SD 9.9). The median period of time between primary thyroid tumor diagnosis and the SpM event was 31.4 months (SD 71.6). In univariate analysis, good ECOG-PS (status 0 and 1) (p < 0.0001), ambulatory status (Frankel score) (p < 0.0001) and no epidural involvement (p = 0.01), were associated with longer survival, whereas cancer subtype (p = 0.436) and spine surgery showed no association (p = 0.937). Cox multivariate proportional hazard model only identified good ECOG-PS: 0 [HR: 0.3, 95% CI 0.1-0.941; p < 0.0001], 1 [HR: 0.8, 95% CI 0.04-2.124; p = 0.001] and ambulatory neurological status: Frankel E [HR: 0.262, 95% CI 0.048-1.443; p = 0.02] to be independent predictors of better survival. CONCLUSION: For cases presenting SpM from TC, we highlighted that the only prognostic factors were the progression of the cancer (ECOG-PS) and the clinical neurological impact of the SpM (Frankel status). Surgery should be discussed mainly for stabilization and neurological decompression.


Assuntos
Adenocarcinoma Folicular/secundário , Carcinoma Neuroendócrino/secundário , Neoplasias da Coluna Vertebral/secundário , Câncer Papilífero da Tireoide/secundário , Neoplasias da Glândula Tireoide/patologia , Adenocarcinoma Folicular/fisiopatologia , Adenocarcinoma Folicular/terapia , Idoso , Carcinoma Neuroendócrino/fisiopatologia , Carcinoma Neuroendócrino/terapia , Feminino , Humanos , Masculino , Metastasectomia , Pessoa de Meia-Idade , Desempenho Físico Funcional , Modelos de Riscos Proporcionais , Radioterapia , Neoplasias da Coluna Vertebral/fisiopatologia , Neoplasias da Coluna Vertebral/terapia , Taxa de Sobrevida , Câncer Papilífero da Tireoide/fisiopatologia , Câncer Papilífero da Tireoide/terapia , Neoplasias da Glândula Tireoide/fisiopatologia , Neoplasias da Glândula Tireoide/secundário , Neoplasias da Glândula Tireoide/terapia , Fatores de Tempo
4.
Head Neck ; 39(2): 361-369, 2017 02.
Artigo em Inglês | MEDLINE | ID: mdl-27704650

RESUMO

BACKGROUND: The purpose of this study was to evaluate the role of core-needle biopsy (CNB) by comparing the results of CNB and repeat fine-needle aspiration (FNA) for thyroid nodules that are initially read as atypia/follicular lesion of undetermined significance (AUS/FLUS) on FNA. METHODS: Among 2631 initial AUS/FLUS FNA results, 505 consecutive nodules (295 repeat FNAs and 210 CNBs) were retrospectively analyzed. The primary outcome was inconclusive (ie, nondiagnostic or AUS/FLUS). The secondary outcomes included inconclusive results of the subcategory, risk factors for inconclusive results, and diagnostic performance. RESULTS: CNB demonstrated significantly fewer inconclusive results than repeat FNA for the overall nodules (40.9% vs 63%; p < .001). Repeat FNA and group FLUS were significant risk factors for inconclusive results (odds ratio = 1.92; p =.001 and odds ratio = 2.08; p <.001, respectively). All diagnostic performances using CNB were higher than repeat FNAs. CONCLUSION: CNB is more useful than repeat FNAs for reducing inconclusive results and improving the diagnostic performance of thyroid nodules with initial AUS/FLUS FNA results. © 2016 Wiley Periodicals, Inc. Head Neck 39: 361-369, 2017.


Assuntos
Adenocarcinoma Folicular/patologia , Biópsia Guiada por Imagem/métodos , Neoplasias da Glândula Tireoide/patologia , Nódulo da Glândula Tireoide/patologia , Ultrassonografia Doppler/métodos , Adenocarcinoma Folicular/fisiopatologia , Adulto , Idoso , Biópsia por Agulha Fina/métodos , Biópsia com Agulha de Grande Calibre/métodos , Estudos de Coortes , Diagnóstico Diferencial , Feminino , Humanos , Imuno-Histoquímica , Japão , Masculino , Pessoa de Meia-Idade , Avaliação de Resultados em Cuidados de Saúde , Valor Preditivo dos Testes , Estudos Retrospectivos , Sensibilidade e Especificidade , Neoplasias da Glândula Tireoide/fisiopatologia , Nódulo da Glândula Tireoide/fisiopatologia
5.
Endocr J ; 63(3): 257-61, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-26655349

RESUMO

Metastatic differentiated thyroid carcinoma (DTC) is an uncommon cause of malignant pleural effusion (MPE) and the characteristics and clinical course have been rarely described. Herein, we report a retrospective review of the clinical course of 18 patients (15 women and 3 men) with MPE from DTC who underwent treatment at our institution between January 2005 and December 2014. MPE from DTC was diagnosed based on cytology and/or level of thyroglobulin in the pleural fluid. Pathologically, papillary carcinoma was found in 16 patients and follicular carcinoma in 2 patients. Median ages at initial diagnosis of DTC and MPE were 64 years (range, 22-79) and 74 years (range, 39-86), respectively. All patients showed radiologically apparent lung metastases, with MPE developing after 0-212 months (median, 25). In 16 patients (88.9%), other coexistent distant metastases at the time of MPE diagnosis were found in the bone (n = 10), brain (n = 5), and skin (n = 2). All patients were treated conservatively with palliative thoracentesis or chest tube drainage with or without pleurodesis. Recurrent MPE after treatment was seen in 9 patients; discharge to home health care after treatment for MPE was possible for 14 patients. The overall survival after initial diagnosis varied considerably from 14 months to 37 years, but the median survival after appearance of MPE was 10 months (range, 1-28). Systemic therapy for iodine-resistant recurrent thyroid disease may need to be considered as a treatment option for patients with MPE.


Assuntos
Adenocarcinoma Folicular/fisiopatologia , Carcinoma Papilar/fisiopatologia , Neoplasias Pulmonares/secundário , Derrame Pleural Maligno/etiologia , Glândula Tireoide/patologia , Neoplasias da Glândula Tireoide/fisiopatologia , Adenocarcinoma Folicular/patologia , Adenocarcinoma Folicular/secundário , Adenocarcinoma Folicular/cirurgia , Adulto , Idoso , Carcinoma/patologia , Carcinoma/fisiopatologia , Carcinoma/cirurgia , Carcinoma Papilar/patologia , Carcinoma Papilar/secundário , Carcinoma Papilar/cirurgia , Feminino , Hospitais Urbanos , Humanos , Japão , Neoplasias Pulmonares/diagnóstico por imagem , Neoplasias Pulmonares/fisiopatologia , Neoplasias Pulmonares/terapia , Excisão de Linfonodo/efeitos adversos , Masculino , Pessoa de Meia-Idade , Estadiamento de Neoplasias , Cuidados Paliativos , Derrame Pleural Maligno/diagnóstico , Derrame Pleural Maligno/fisiopatologia , Derrame Pleural Maligno/terapia , Prognóstico , Estudos Retrospectivos , Análise de Sobrevida , Câncer Papilífero da Tireoide , Glândula Tireoide/cirurgia , Neoplasias da Glândula Tireoide/patologia , Neoplasias da Glândula Tireoide/cirurgia , Tireoidectomia/efeitos adversos , Adulto Jovem
6.
Thyroid ; 25(9): 987-92, 2015 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-26114752

RESUMO

BACKGROUND: Increased recognition of the indolent nature of noninvasive follicular variant of papillary thyroid carcinoma (NFVPTC) along with greater insight into the molecular alterations of these tumors has prompted endocrine pathologists to question whether these tumors warrant a diagnosis of carcinoma. However, a change in terminology would affect the rates of malignancy of fine-needle aspiration (FNA) diagnostic categories. Therefore, the aim of this study was to determine the percentage decrease in associated risk of malignancy for each FNA diagnostic category if NFVPTCs were no longer termed carcinomas. METHODS: We evaluated a cohort of 655 FNAs with subsequent resection specimens over a 22-month time period. The diagnoses of the preceding FNAs were recorded according to the Bethesda System for Reporting Thyroid Cytopathology. For cases with more than one preceding FNA, the FNA diagnosis associated with the highest risk of malignancy was identified. Slides for all resection specimens with a diagnosis of FVPTC were reviewed to identify noninvasive tumors. By definition, all of these tumors were encapsulated, partially encapsulated, or well circumscribed and lacked any indication of infiltrative growth, capsular penetration, or lymphovascular invasion. RESULTS: Our cohort of 655 FNAs with subsequent resection specimens included 53 (8.1%) nondiagnostic (ND), 167 (25.5%) benign, 97 (14.8%) atypia/follicular lesion of undetermined significance (AUS/FLUS), 88 (13.4%) suspicious for follicular neoplasm (SFN), 94 (14.4%) suspicious for malignancy (SUS), and 156 (23.8%) malignant cases (POS). Surgical resections demonstrated benign findings in 309 (47.2%) and malignant tumors in 346 (52.8%), including 85 NFVPTCs accounting for 24.6% of malignancies. Our rates of malignancy for ND, benign, AUS/FLUS, SFN, SUS, and POS were 18.9%, 13.2%, 39.2%, 45.5%, 87.2%, and 98.7%, respectively. If NFVPTC were no longer termed carcinoma, these rates would drop to 17.0% (10% decrease), 5.4% (59% decrease), 21.6% (45% decrease), 37.5% (18% decrease), 45.7% (48% decrease), and 93.6% (5% decrease), respectively. CONCLUSION: Our findings demonstrate that if terminology were changed and NFVPTCs were not considered carcinomas, the rates of malignancy for FNA diagnostic categories would be substantially decreased, with the most clinically significant decrease seen in the SUS category, which demonstrated a relative decrease of nearly 50%.


Assuntos
Adenocarcinoma Folicular/diagnóstico , Adenocarcinoma Folicular/fisiopatologia , Biópsia por Agulha Fina/métodos , Carcinoma/diagnóstico , Carcinoma/fisiopatologia , Neoplasias da Glândula Tireoide/diagnóstico , Neoplasias da Glândula Tireoide/fisiopatologia , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Carcinoma Papilar , Estudos de Coortes , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Câncer Papilífero da Tireoide , Glândula Tireoide/fisiopatologia , Nódulo da Glândula Tireoide/fisiopatologia , Adulto Jovem
7.
J Biol Rhythms ; 30(2): 76-83, 2015 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-25411240

RESUMO

The circadian clock represents an anticipatory mechanism, well preserved in evolution. It has a critical impact on most aspects of the physiology of light-sensitive organisms. These rhythmic processes are governed by environmental cues (fluctuations in light intensity and temperature), an internal circadian timing system, and interactions between this timekeeping system and environmental signals. Endocrine body rhythms, including hypothalamic-pituitary-thyroid (HPT) axis rhythms, are tightly regulated by the circadian system. Although the circadian profiles of thyroid-releasing hormone (TRH), thyroid-stimulating hormone (TSH), thyroxine (T4), and triiodothyronine (T3) in blood have been well described, relatively few studies have analyzed molecular mechanisms governing the circadian regulation of HPT axis function. In this review, we will discuss the latest findings in the area of complex regulation of thyroid gland function by the circadian oscillator. We will also highlight the molecular makeup of the human thyroid oscillator as well as the potential link between thyroid malignant transformation and alterations in the clockwork.


Assuntos
Relógios Biológicos/genética , Ritmo Circadiano/genética , Glândula Tireoide/fisiologia , Neoplasias da Glândula Tireoide/fisiopatologia , Adenocarcinoma Folicular/genética , Adenocarcinoma Folicular/fisiopatologia , Animais , Relógios Biológicos/fisiologia , Humanos , Hipotálamo/fisiologia , Hipófise/fisiologia , Neoplasias da Glândula Tireoide/genética
8.
Clin Endocrinol (Oxf) ; 82(2): 295-9, 2015 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-25138547

RESUMO

OBJECTIVE: To evaluate the effects of radioactive iodine (RAI) treatment for differentiated thyroid cancer (DTC) on testis function. DESIGN: A prospective longitudinal single-centre study was performed. A comprehensive andrological evaluation including hormonal assessment, semen analysis and scrotal ultrasound was undertaken in male patients undergoing RAI treatment for DTC. METHODS: Hormonal assessment of FSH, LH, testosterone (T), sperm concentration and motility and testis volume were determined in 20 patients in basal conditions, 6 and 12 months after RAI. Results were analysed in the whole group of patients and then separately in those who received one single ablative treatment ('Single' group, n = 10) and those who received multiple treatments ('Multiple' group, n = 10). RESULTS: In basal conditions, 3 of 20 (15%) patients had a reduced sperm count and belonged to the 'Multiple' group. After RAI, an increase of FSH (8·8 ± 1·2 UI/l vs 5·2 ± 1·2, P < 0·005) and a decrease in sperm concentration (28·8 ± 7·7 millions/ml vs 54·5 ± 7·1, P < 0·005) and testis volume (15·2 ± 3·1 vs 13·7 ± 0·8 ml, P < 0·005) occurred at 6 months in the whole group. One year after RAI, seven patients had oligozoospermia (five from the 'Multiple' group and two from the 'Single' group). Permanent impairment of one or more testis function parameters was observed in patients who underwent multiple RAI treatments: 50% for sperm count, 40% for FSH levels and testis volume and, respectively, in 20 and 10% of those who received one single RAI treatment. CONCLUSIONS: The single ablative RAI treatment in cancer patients is better tolerated respect multiple RAI treatments regard testis function. Multiple treatments for recurrent or metastatic disease may cause a permanent impairment of one or more parameters related to the reproductive potential of male patients.


Assuntos
Radioisótopos do Iodo/uso terapêutico , Testículo/fisiopatologia , Neoplasias da Glândula Tireoide/radioterapia , Adenocarcinoma Folicular/sangue , Adenocarcinoma Folicular/diagnóstico por imagem , Adenocarcinoma Folicular/fisiopatologia , Adenocarcinoma Folicular/radioterapia , Adulto , Carcinoma/sangue , Carcinoma/diagnóstico por imagem , Carcinoma/fisiopatologia , Carcinoma/radioterapia , Carcinoma Papilar , Hormônio Foliculoestimulante/sangue , Humanos , Estudos Longitudinais , Hormônio Luteinizante/sangue , Masculino , Tamanho do Órgão , Análise do Sêmen , Testículo/diagnóstico por imagem , Testículo/patologia , Testículo/efeitos da radiação , Testosterona/sangue , Câncer Papilífero da Tireoide , Neoplasias da Glândula Tireoide/sangue , Neoplasias da Glândula Tireoide/diagnóstico por imagem , Neoplasias da Glândula Tireoide/fisiopatologia , Ultrassonografia , Adulto Jovem
9.
J Vet Intern Med ; 28(6): 1814-23, 2014.
Artigo em Inglês | MEDLINE | ID: mdl-25231196

RESUMO

BACKGROUND: Information on the genetic events leading to thyroid cancer in dogs is lacking. HYPOTHESIS/OBJECTIVES: Upregulation of the PI3K/Akt pathway has an important role in the tumorigenesis of thyroid carcinoma in dogs. ANIMALS: Fifty-nine dogs with thyroid carcinoma and 10 healthy controls. METHODS: Quantitative RT-PCR was performed for VEGFR-1, VEGFR-2, EGFR, PIK3CA, PIK3CB, PDPK1, PTEN, AKT1, AKT2, COX-2, and CALCA. Mutation analysis was performed for known hotspots of RAS (N, K, H), PIK3CA, BRAF, RET, and for the entire coding region of PTEN. RESULTS: Forty-three dogs (73%) had follicular cell thyroid carcinoma (FTC) and 16 dogs (27%) had medullary thyroid carcinoma (MTC). The relative mRNA expressions of VEGFR-1 (P < .001), VEGFR-2 (P = .002), PDPK1 (P < .001), AKT1 (P = .009), and AKT2 (P < .001) were increased in FTC, and those of EGFR (P < .001), VEGFR-1 (P = .036), and PIK3CA (P = .019) were increased in MTC when compared to normal thyroid glands. Mutation analysis of K-RAS identified 2 activating missense mutations, which also have been described in thyroid cancer of humans. A G12R substitution was present in 1 FTC and an E63K substitution was present in 1 MTC. No functional mutations were found in the sequenced regions of H-RAS, N-RAS, PIK3CA, BRAF, RET, and PTEN. CONCLUSIONS AND CLINICAL IMPORTANCE: The increased expression of several genes associated with PI3K/Akt signaling suggests the involvement of this pathway in the pathogenesis of thyroid carcinoma in dogs, warranting further research on pathway activation and gene amplification. The mutations most frequently associated with thyroid cancer in humans are rare in dogs.


Assuntos
Doenças do Cão/fisiopatologia , Proteína Oncogênica v-akt/fisiologia , Fosfatidilinositol 3-Quinases/fisiologia , Transdução de Sinais/fisiologia , Neoplasias da Glândula Tireoide/veterinária , Adenocarcinoma Folicular/patologia , Adenocarcinoma Folicular/fisiopatologia , Adenocarcinoma Folicular/veterinária , Animais , Carcinoma Neuroendócrino/patologia , Carcinoma Neuroendócrino/fisiopatologia , Carcinoma Neuroendócrino/veterinária , Estudos de Casos e Controles , Doenças do Cão/patologia , Cães , Regulação Neoplásica da Expressão Gênica/fisiologia , Proteína Oncogênica v-akt/biossíntese , Fosfatidilinositol 3-Quinases/biossíntese , Reação em Cadeia da Polimerase/veterinária , Glândula Tireoide/patologia , Neoplasias da Glândula Tireoide/patologia , Neoplasias da Glândula Tireoide/fisiopatologia , Regulação para Cima/fisiologia
10.
Folia Neuropathol ; 51(3): 261-8, 2013.
Artigo em Inglês | MEDLINE | ID: mdl-24114644

RESUMO

Metastases to the pituitary gland and sella turcica are uncommon. The distinction between primary and secondary metastatic pituitary tumours is challenging as carcinomas from distant sites might closely resemble, both clinically and histopathologically, non-functional adenomas or primary pituitary carcinomas. Among metastases to pituitary gland ones from thyroid carcinoma are extremely rare. We present a unique case of a 53-year-old male patient with a past history of thyroid carcinoma who underwent repeated surgeries over a period of 7 years for a sellar-parasellar mass with paranasal sinus involvement. Morphologically, the tumour was composed of solid sheaths of monomorphic cells exhibiting oncocytic features. In electron microscope images, the cytoplasm of tumour cells was filled with numerous mitochondria. The tumour was negative for pituitary hormones but exhibited immunoreactivity for cytokeratin AE1/AE3, thyroglobulin and thyroid transcription factor 1 (TTF-1). Based on the clinical data and immunophenotypic profile, the tumour was finally diagnosed as an oncocytic variant of follicular thyroid carcinoma. To our knowledge, this is probably the first report of such peculiar histopathological variant of follicular thyroid carcinoma metastasizing to the pituitary gland. The diagnostic dilemmas considering oncocytic features of the presented case are discussed.


Assuntos
Adenocarcinoma Folicular/patologia , Adenoma Oxífilo/secundário , Neoplasias Hipofisárias/secundário , Adenocarcinoma Folicular/fisiopatologia , Adenoma Oxífilo/fisiopatologia , Erros de Diagnóstico , Humanos , Masculino , Pessoa de Meia-Idade , Neoplasias Hipofisárias/diagnóstico , Neoplasias Hipofisárias/fisiopatologia , Neoplasias Hipofisárias/cirurgia
12.
J Clin Endocrinol Metab ; 98(11): 4446-56, 2013 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-23979949

RESUMO

CONTEXT: The circadian clock represents the body's molecular time-keeping system. Recent findings revealed strong changes of clock gene expression in various types of human cancers. OBJECTIVE: Due to emerging evidence on the connection between the circadian oscillator, cell cycle, and oncogenic transformation, we aimed to characterize the circadian clockwork in human benign and malignant thyroid nodules. DESIGN: Clock transcript levels were assessed by quantitative RT-PCR in thyroid tissues. To provide molecular characteristics of human thyroid clockwork, primary thyrocytes established from normal or nodular thyroid tissue biopsies were subjected to in vitro synchronization with subsequent clock gene expression analysis by circadian bioluminescence reporter assay and by quantitative RT-PCR. RESULTS: The expression levels of the Bmal1 were up-regulated in tissue samples of follicular thyroid carcinoma (FTC), and in papillary thyroid carcinoma (PTC), as compared with normal thyroid and benign nodules, whereas Cry2 was down-regulated in FTC and PTC. Human thyrocytes derived from normal thyroid tissue exhibited high-amplitude circadian oscillations of Bmal1-luciferase reporter expression and endogenous clock transcripts. Thyrocytes established from FTC and PTC exhibited clock transcript oscillations similar to those of normal thyroid tissue and benign nodules (except for Per2 altered in PTC), whereas cells derived from poorly differentiated thyroid carcinoma exhibited altered circadian oscillations. CONCLUSIONS: This is the first study demonstrating a molecular makeup of the human thyroid circadian clock. Characterization of the thyroid clock machinery alterations upon thyroid nodule malignant transformation contributes to understanding the connections between circadian clocks and oncogenic transformation. Moreover, it might help in improving the thyroid nodule preoperative diagnostics.


Assuntos
Adenocarcinoma Folicular/fisiopatologia , Carcinoma/fisiopatologia , Transtornos Cronobiológicos/fisiopatologia , Ritmo Circadiano/genética , Neoplasias da Glândula Tireoide/fisiopatologia , Nódulo da Glândula Tireoide/fisiopatologia , Transcriptoma , Adenocarcinoma Folicular/genética , Adenocarcinoma Folicular/cirurgia , Adulto , Idoso , Idoso de 80 Anos ou mais , Carcinoma/genética , Carcinoma/cirurgia , Carcinoma Papilar , Transtornos Cronobiológicos/genética , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Modelos Genéticos , Cultura Primária de Células , Câncer Papilífero da Tireoide , Glândula Tireoide/fisiopatologia , Neoplasias da Glândula Tireoide/genética , Neoplasias da Glândula Tireoide/cirurgia , Nódulo da Glândula Tireoide/genética , Nódulo da Glândula Tireoide/cirurgia , Tireoidectomia , Adulto Jovem
13.
Thyroid ; 23(1): 64-9, 2013 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-22971127

RESUMO

BACKGROUND: External beam radiotherapy (XRT) has an established role in the management of recurrent or advanced well-differentiated thyroid carcinoma (WDTC). The goal of this study was to investigate the impact of this additional intervention on the quality of life (QOL) compared with total thyroidectomy (TT), with or without adjuvant radioactive iodine (RAI). METHODS: A cross-sectional analysis using validated QOL instruments was performed. Patients receiving XRT between 1992 and 2008 for WDTC were identified and offered study participation. The Quality of Life Radiation Therapy Instrument and the Head and Neck Companion Module were administered retrospectively (N=13). For a comparison, patients previously treated with TT (N=11) alone as well as TT with postoperative RAI (N=11) for WDTC were also evaluated. RESULTS: Thirty-four patients were included in the analysis. The XRT group reported significant decreases in chewing, swallowing, and appetite, and significant increase in pain, compared with both the RAI group and the TT group. Significant differences were reported for questions with regard to peace of mind, feeling discouraged, saliva, taste, ability to eat regular food, and concerns for the appearance of the neck in both RAI and XRT groups compared with TT patients. Subscale analysis of head and neck specific questions demonstrated significant overall differences for both RAI and XRT groups compared with thyroidectomy alone, with no differences observed between RAI and XRT groups in a direct comparison. CONCLUSIONS: RAI therapy results in a measurable decrease in head and neck specific QOL measures compared with TT alone. The addition of XRT results in additional measurable morbidity secondary to pain and dysphagia.


Assuntos
Neoplasias da Glândula Tireoide/radioterapia , Adenocarcinoma Folicular/fisiopatologia , Adenocarcinoma Folicular/radioterapia , Adenocarcinoma Folicular/cirurgia , Adulto , Idoso , Carcinoma/fisiopatologia , Carcinoma/radioterapia , Carcinoma/cirurgia , Carcinoma Papilar , Estudos Transversais , Transtornos de Deglutição/etiologia , Feminino , Humanos , Radioisótopos do Iodo/uso terapêutico , Masculino , Pessoa de Meia-Idade , Recidiva Local de Neoplasia/fisiopatologia , Recidiva Local de Neoplasia/radioterapia , Dor/etiologia , Qualidade de Vida , Radioterapia Adjuvante , Estudos Retrospectivos , Inquéritos e Questionários , Câncer Papilífero da Tireoide , Neoplasias da Glândula Tireoide/fisiopatologia , Neoplasias da Glândula Tireoide/cirurgia , Tireoidectomia
14.
Surgery ; 152(6): 1218-24, 2012 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-23158188

RESUMO

BACKGROUND: EphA2 is a tyrosine kinase receptor that is overexpressed in many cancers and is associated with poor prognosis and increased metastasis. Phosphorylated Akt (pAkt) plays a role in the regulation of thyroid cancer invasion and metastasis. We investigated the role of EphA2 and Akt in FTC-133 and FTC-238, 2 closely related human cell lines with differing invasive phenotypes. METHODS: Western blot was used to measure the total protein expression in cell lines, and immunohistochemistry was performed on thyroid tissue microarrays. Thyroid cell lines were transfected with siRNA or cDNA. Invasion assays were performed using Matrigel chambers, and invaded cells were assayed with (3-(4,5dimethylthiazol-2-yl)-2,5-diphenyltetrazoliumbromide (MTT). RESULTS: EphA2 protein was expressed in thyroid cancer cell lines and in benign and malignant human thyroid tumors but not in normal thyroid. Compared with FTC-133, FTC-238 expressed fivefold more EphA2 protein and had a fivefold increase in invasion (P < .001). In FTC-238, EphA2 siRNA decreased EphA2 levels and reduced invasion, with a decrease in pAkt protein. Overexpression of EphA2 in FTC-133 increased invasion and increased pAkt protein. Akt siRNA and Akt inhibitors decreased pAkt levels and invasion without changing EphA2 levels. CONCLUSION: EphA2 is expressed in human thyroid cancer and mediates invasion in the follicular thyroid cell lines FTC-133 and -238. Phosphorylated Akt (pAkt), an important regulator of thyroid cancer metastasis, is attenuated by EphA2 knockdown, providing evidence that EphA2 may act through pAkt to mediate invasion. EphA2 and pAkt may be candidates for targeted therapy against metastatic thyroid cancer.


Assuntos
Adenocarcinoma Folicular/fisiopatologia , Proteínas Proto-Oncogênicas c-akt/fisiologia , Receptor EphA2/fisiologia , Neoplasias da Glândula Tireoide/fisiopatologia , Adenocarcinoma Folicular/metabolismo , Linhagem Celular Tumoral , Humanos , Immunoblotting , Invasividade Neoplásica/fisiopatologia , PTEN Fosfo-Hidrolase/metabolismo , Fosforilação , Fosforilcolina/análogos & derivados , Fosforilcolina/farmacologia , Proteínas Proto-Oncogênicas c-akt/antagonistas & inibidores , Proteínas Proto-Oncogênicas c-akt/metabolismo , RNA Interferente Pequeno/farmacologia , Neoplasias da Glândula Tireoide/metabolismo , Células Tumorais Cultivadas
15.
Rehabilitación (Madr., Ed. impr.) ; 45(4): 356-359, oct.-dic. 2011.
Artigo em Espanhol | IBECS | ID: ibc-91531

RESUMO

Habitualmente el carcinoma folicular de tiroides se presenta como un nódulo tiroideo solitario, y excepcionalmente, como una metástasis. En el carcinoma folicular tiroideo después de la vía hematógena y las metástasis en pulmón, el tejido óseo es el segundo lugar más frecuente de dichas metástasis. Se presenta el caso clínico de una mujer de 70 años, que refería dolor en el hombro izquierdo de intensidad moderada-severa y resistente al tratamiento farmacológico, sin sintomatología general acompañante (pérdida de peso, hiporexia y astenia). La radiografía simple y la tomografía computarizada evidenciaron la reabsorción ósea de la escápula. Se trató con radioterapia externa con evolución clínica favorable. El objetivo de la presentación de este caso clínico es enfatizar la etiología de un dolor de hombro, refractaria al tratamiento, que excepcionalmente tenía su origen en un carcinoma tiroideo bien diferenciado de estadio II, diagnosticado 13 años antes (AU)


Follicular thyroid cancer commonly occurs as a solitary thyroid nodule and rarely as metastasis. Following the dematogenous route and lung metastasis, the second most frequent site of these metastases in follicular thyroid cancer is the bone tissue. A clinical case is presented of a 70-year old woman who reported drug treatment-resistant moderate-severe left shoulder pain, without general accompanying symptoms (weight loss, hyporexia and asthenia). The simple x-ray and computed tomography showed bone resorption of the scapula. She was treated with external radiotherapy with good clinical course. We are presenting this clinical case in order to stress the etiology of a shoulder pain that is refractory to treatment and which, uncommonly, originated in a stage II well-differentiated thyroid cancer diagnosed 13 years ago (AU)


Assuntos
Humanos , Feminino , Pessoa de Meia-Idade , Dor de Ombro/complicações , Dor de Ombro/diagnóstico , Dor de Ombro/reabilitação , Adenocarcinoma Folicular/complicações , Adenocarcinoma Folicular/diagnóstico , Adenocarcinoma Folicular/reabilitação , Tiroxina/uso terapêutico , Dor de Ombro/fisiopatologia , Dor de Ombro , Escápula/patologia , Escápula , Adenocarcinoma Folicular/fisiopatologia , Adenocarcinoma Folicular , Metástase Neoplásica/patologia , Ombro/patologia , Ombro
16.
Int J Surg ; 8(3): 186-93, 2010.
Artigo em Inglês | MEDLINE | ID: mdl-20097316

RESUMO

Thyroid cancers are the most common endocrine malignancy. Radiation exposure, family history of thyroid cancer and some inherited conditions are the most important predisposing factors for the development of thyroid cancer. Three mitogenic signalling pathways have been described in the thyroid cell, which are influenced by various stimulatory and inhibitory hormones, growth factors and neurotransmitters. Various proto-oncogenes and oncogenes like ras, braf, trk, met and RET also play a role in the signal transduction systems. Two theories have been described in thyroid cancer pathogenesis, the foetal cell carcinogenesis theory and the more common, multistep carcinogenesis theory. The multistep carcinogenesis theory is now the accepted model in many human cancers, including thyroid cancer. The early events of tumour formation are the consequence of activation of either various growth factors or the proto-oncogenes like ras, met or ret. This results in the formation of differentiated thyroid cancers like the papillary, follicular or Hurthle cell cancers. The later stages of tumour formation involve further activation of proto-oncogenes and loss or inactivation of tumour suppressor genes like p53. Based on this theory, follicular carcinomas are generated from follicular adenomas and papillary carcinomas from precursor cells generated from thyrocytes. Anaplastic carcinoma may develop from papillary or follicular carcinoma by dedifferentiation. In this review article, we highlight the molecular pathogenesis of thyroid tumours.


Assuntos
Neoplasias da Glândula Tireoide/genética , Neoplasias da Glândula Tireoide/fisiopatologia , Adenocarcinoma Folicular/genética , Adenocarcinoma Folicular/fisiopatologia , Adenoma Oxífilo/genética , Adenoma Oxífilo/fisiopatologia , Carcinoma Papilar/genética , Carcinoma Papilar/fisiopatologia , Humanos
17.
J Endocrinol Invest ; 33(2): 88-91, 2010 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-19636214

RESUMO

BACKGROUND: The aim of this study was to measure maximum P wave duration (Pmax) and P wave dispersion (PWD), which can be indicators for the risk of paroxysmal atrial fibrillation when increased, and to reveal their relationship with thyroid hormone levels in patients with endogenous and exogenous subclinical hyperthyroidism. METHODS: Seventy-one patients with sublinical thyrotoxicosis (34 endogenous, 37 exogenous) and 69 healthy individuals were enrolled in the study. Pmax and minimum P wave duration (Pmin) on electrocardiogram recordings were measured and PWD was calculated as Pmax-Pmin. RESULTS: Pmax (p<0.001) and PWD (p<0.001) values were significantly higher in patients with endogenous subclinical hyperthyroidism compared with the control group. Pmax (p<0.001) and PWD (p<0.001) values were significantly higher in patients with exogenous subclinical thyrotoxicosis compared with the control group. Pmax (p=0.710) and PWD (p=0.127) were not significantly different in patients with endogenous subclinical hyperthyroidism compared with exogenous subclinical hyperthyroid patients. Pmax and PWD negatively associated with TSH in endogenous and exogenous subclinical hyperthyroidism. CONCLUSION: In the present study, we observed that Pmax and PWD were longer in patients with endogenous and exogenous subclinical hyperthyroidism. Lack of a difference in Pmax and PWD between patients with endogenous and exogenous subclinical hyperthyroidism seems to support the idea that hormone levels rather than the etiology of thyrotoxicosis affect the heart.


Assuntos
Eletrocardiografia , Hipertireoidismo/complicações , Hipertireoidismo/fisiopatologia , Adenocarcinoma Folicular/fisiopatologia , Adenoma/fisiopatologia , Fibrilação Atrial/diagnóstico , Fibrilação Atrial/etiologia , Carcinoma Papilar/fisiopatologia , Feminino , Bócio Nodular/fisiopatologia , Doença de Graves/fisiopatologia , Humanos , Pessoa de Meia-Idade , Neoplasias da Glândula Tireoide/fisiopatologia , Tireotropina/sangue , Tiroxina/sangue , Tri-Iodotironina/sangue
18.
Thyroid ; 19(12): 1317-31, 2009 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-20001715

RESUMO

BACKGROUND: Thyroid cancer is the most common endocrine tumor and is increasing in incidence. The aim of this study was to review mouse models of differentiated thyroid cancer and how they elucidate human thyroid cancer biology. SUMMARY: Differentiated thyroid cancer, primarily papillary and follicular, comprises the majority of thyroid cancers. There has been tremendous growth in the cross-talk between basic science and clinical practice for thyroid cancer management. Insight into the framework of genes responsible for differentiated thyroid cancer has been gained through the use of mouse models. Common genetic alterations found in human papillary thyroid cancer such as RET/PTC rearrangements or the BRAF(V600E) mutation have genetically modified mouse counterparts. These and other preclinical mouse models have validated the importance of the cyclic adenosine monophosphate (cAMP)/protein kinase A and mitogen-activated protein kinase (MAPK) signaling pathways in papillary thyroid cancer (PTC). RAS mutations have a role in both papillary and follicular thyroid cancer development. Mice with overactivation of the phosphatidylinol-3-kinase (PI3K)-AKT and/or thyrotropin-regulated signaling pathways have been found to develop follicular thyroid cancer. Additional mouse models of thyroid cancer that utilize inducible expression systems are in development or are being characterized and will better reflect the majority of human thyroid cancers which are non-hereditary. Advances in in vivo imaging of mice allow for earlier detection of metastasis and the ability to follow tumor growth or regression which may be used in evaluation of pharmaceutical agents. CONCLUSIONS: Mouse models have expanded our understanding of the altered signaling pathways that contribute to thyroid cancer tumorigenesis and provide a powerful tool to develop novel diagnostic approaches and therapies.


Assuntos
Neoplasias da Glândula Tireoide/genética , Adenocarcinoma Folicular/genética , Adenocarcinoma Folicular/fisiopatologia , Animais , Carcinoma Papilar/genética , Carcinoma Papilar/fisiopatologia , AMP Cíclico/fisiologia , Humanos , Sistema de Sinalização das MAP Quinases/fisiologia , Camundongos , Camundongos Transgênicos , Modelos Animais , Proteínas Proto-Oncogênicas B-raf/genética , Receptor trkA/genética , Receptor trkA/fisiologia , Receptores da Tireotropina/fisiologia , Transdução de Sinais/fisiologia , Neoplasias da Glândula Tireoide/fisiopatologia , Proteínas ras/genética , Proteínas ras/fisiologia
19.
BMC Cancer ; 9: 369, 2009 Oct 18.
Artigo em Inglês | MEDLINE | ID: mdl-19835629

RESUMO

BACKGROUND: Carcinoma of the thyroid gland is an uncommon cancer, but the most frequent malignancy of the endocrine system. Most thyroid cancers are derived from the follicular cell. Follicular carcinoma (FTC) is considered more malignant than papillary thyroid carcinoma (PTC), and anaplastic thyroid cancer (ATC) is one of the most lethal human cancers. Opioid Growth Factor (OGF; chemical term - [Met5]-enkephalin) and its receptor, OGFr, form an inhibitory axis regulating cell proliferation. Both the peptide and receptor have been detected in a wide variety of cancers, and OGF is currently used clinically as a biotherapy for some non-thyroid neoplasias. This study addressed the question of whether the OGF-OGFr axis is present and functional in human thyroid follicular cell - derived cancer. METHODS: Utilizing human ATC (KAT-18), PTC (KTC-1), and FTC (WRO 82-1) cell lines, immunohistochemistry was employed to ascertain the presence and location of OGF and OGFr. The growth characteristics in the presence of OGF or the opioid antagonist naltrexone (NTX), and the specificity of opioid peptides for proliferation of ATC, were established in KAT-18 cells. Dependence on peptide and receptor were investigated using neutralization studies with antibodies and siRNA experiments, respectively. The mechanism of peptide action on DNA synthesis and cell survival was ascertained. The ubiquity of the OGF-OGFr axis in thyroid follicular cell-derived cancer was assessed in KTC-1 (PTC) and WRO 82-1 (FTC) tumor cells. RESULTS: OGF and OGFr were present in KAT-18 cells. Concentrations of 10-6 M OGF inhibited cell replication up to 30%, whereas NTX increased cell growth up to 35% relative to cultures treated with sterile water. OGF treatment reduced cell number by as much as 38% in KAT-18 ATC in a dose-dependent and receptor-mediated manner. OGF antibodies neutralized the inhibitory effects of OGF, and siRNA knockdown of OGFr negated growth inhibition by OGF. Cell survival was not altered by OGF, but DNA synthesis as recorded by BrdU incorporation was depressed by 28% in OGF-treated cultures compared to those exposed to sterile water. The OGF-OGFr axis was detected and functional in PTC (KTC-1) and FTC (WRO 82-1) cell lines. CONCLUSION: These data suggest that OGF and OGFr are present in follicular-derived thyroid cancers, and that OGF serves in a tonically active inhibitory manner to maintain homeostasis of cell proliferation. These results may provide a biotherapeutic strategy in the treatment of these cancers.


Assuntos
Adenocarcinoma Folicular/metabolismo , Proliferação de Células , Encefalina Metionina/metabolismo , Receptores Opioides/metabolismo , Neoplasias da Glândula Tireoide/metabolismo , Adenocarcinoma Folicular/tratamento farmacológico , Adenocarcinoma Folicular/genética , Adenocarcinoma Folicular/fisiopatologia , Linhagem Celular Tumoral , Proliferação de Células/efeitos dos fármacos , Encefalina Metionina/farmacologia , Humanos , Receptores Opioides/genética , Neoplasias da Glândula Tireoide/tratamento farmacológico , Neoplasias da Glândula Tireoide/genética , Neoplasias da Glândula Tireoide/fisiopatologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...